RWS Life Sciences offers translation, content management and intellectual property services for pharmaceutical and life sciences companies. We connect customers with people worldwide by communicating content at scale, to allow ideas and innovations to be protected and realised.
We provide localisation, translation and transcreation services, as well as translation management technology, machine translation and translation productivity tools, to help companies expand their reach globally.
Our solutions can help you make processes more efficient, lower translation costs, and expedite time to market. They can increase real value for your teams and ecosystem partners to improve outcomes for scientists, medical representatives, professionals, and patients.
Accurate translations for clinical trials
Translations are essential for advancing clinical trials, and RWS’ understanding of and emphasis on the life sciences industry allows us to confidently handle all translation requests.
Our clinical trial management services begin by thoroughly analysing projects, allowing us to discern the most appropriate translation solution for each request and customise as necessary. We follow flexible procedures so we can deliver in the most timely and cost-effective manner.
Documents we can translate include protocols, protocol synopses, case report forms (CRFs), electronic clinical outcomes assessments (eCOAs), adverse event reports, electronic patient-reported outcomes (ePROs), patient records, and event logs.
Linguistic validation for clinical outcome assessments
RWS is a dependable partner for the linguistic validation and management of clinical outcomes assessments (COAs). Our translations are accurate and match the source instrument in conceptual and cultural terms, whether the assessment is for a patient, clinician or observer.
Our linguistic validation process is based on the US Food and Drug Administration’s (FDA) patient-reported outcome (PRO) guidance document, as well as the good practice recommendations set out by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
We partner with translators, interviewers, instrument developers, survey research experts, clinicians and in-country reviewers worldwide, allowing us to undertake each validation project with ease and scientific accuracy.
Regulatory document translation capabilities
Patient safety depends on accurate pharmaceutical product information, so RWS prioritises translating product materials accurately. Our industry specialisation and knowledge of regulatory standards and terminology guarantee accurate and timely translation.
All our translations are translated by two highly qualified linguists and undergo multilingual multimedia production, a further quality control edit, a final pre-production review, and a domestic review before being certified.
Our translations follow methods stipulated by global healthcare regulatory bodies, including the European Medicines Agency (EMA).
We can translate a wide range of pharmaceutical product documents, including patient information leaflets (PILs), summaries of product characteristics (SmPCs), pharmaceutical product information, packaging inserts, patient prescription information, and regulatory correspondence.
Translation services for medical and in-vitro devices
RWS’s translation experts and linguists are committed to handling the unique requirements of medical and in-vitro device projects, including labelling, product manuals and patents.
Through our ISO 13485-certified translation processes, routine risk assessment procedures, technology solutions, and intelligent use of translation memory, we can provide clients with translations of the highest possible quality.
Among other documents, we can translate packaging inserts and labels, usage instructions, operating and installation manuals, manufacturing procedures, patents, data sheets, regulatory compliance documents, and software applications.
About RWS Life Sciences
RWS has more than 60 years’ worth of translation experience and knowledge. We take clients’ content and ideas to worldwide audiences using our smart technology, deep expertise, and collective global intelligence.
We partner with pharmaceutical, medical, chemical, technology, financial services, legal, telecommunications and automotive companies, as well as governmental organisations, in Europe, Asia-Pacific, North America, and South America.